Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

Florida's plan to drop school vaccine rule won't start for 90 days, won't cover all diseases

  • medicalxpress.com language
  • 2025-09-08 14:35 event
  • 2 weeks ago schedule
Florida's plan to drop school vaccine rule won't start for 90 days, won't cover all diseases
Florida's plan to drop school vaccine mandates likely won't take effect for 90 days and would include only chickenpox and a few other illnesses unless lawmakers decide to extend it to other diseases, like polio and measles, the health department said Sunday.

829. Substance use during pregnancy can harm a fetus, experts warn

  • 2 weeks ago schedule
  • medicalxpress.com language

Using alcohol, tobacco, marijuana or other substances during pregnancy can harm the developing fetus, even when the risks are not always obvious, a West Virginia University psychiatrist warns.

830. When hospitals and insurers fight, patients get caught in the middle

  • 2 weeks ago schedule
  • medicalxpress.com language

Amy Frank said it took 17 hours on the phone over nearly three weeks, bouncing between her insurer and her local hospital system, to make sure her plan would cover her husband's post-surgery care.

831. Clinical trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

  • 2 weeks ago schedule
  • medicalxpress.com language

Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest that adjuvant chemo-immunotherapy may reduce the risk of recurrence in patients with completely resected stage IB–IIIA non-small cell lung cancer (NSCLC) while maintaining an acceptable safety profile.

832. No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

  • 2 weeks ago schedule
  • medicalxpress.com language

Treating patients who have stage III non-small cell lung cancer (NSCLC) with durvalumab concurrent with chemoradiotherapy (CRT) and continuing as consolidation therapy did not improve overall survival compared to consolidation durvalumab alone, according to research presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC).

833. FDA warns of juice recall linked to potential foodborne illness

  • 2 weeks ago schedule
  • medicalxpress.com language

Parents in New Jersey, Pennsylvania and New York may want to pause before they pack a juice drink in their child's lunchbox.

834. BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

  • 2 weeks ago schedule
  • medicalxpress.com language

BMS-986504, a first-in-class methylthioadenosine (MTA)-cooperative protein arginine methyltransferase 5 (PRMT5) targeting agent, showed promising antitumor activity in heavily pretreated patients with MTAP-deleted non-small cell lung cancer (NSCLC), according to results from the Phase I CA240-0007 trial presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC).

835. Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

  • 2 weeks ago schedule
  • medicalxpress.com language

Older individuals between the ages of 75 and 80 who are eligible for lung surgery may achieve survival outcomes comparable to younger patients following lung cancer screening, according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer (WCLC 2025) held in Barcelona.

836. Video-assisted thoracoscopy surgery reduces mortality by 21% compared to lobectomy, meta-analysis suggests

  • 2 weeks ago schedule
  • medicalxpress.com language

Patients who underwent video-assisted thoracoscopic surgery (VATS) compared to open lobectomy had a significantly improved overall survival rate, according to a meta-analysis presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC).

837. Hypofractionated radiotherapy with chemotherapy offers comparable survival, lower toxicity in LS-SCLC

  • 2 weeks ago schedule
  • medicalxpress.com language

A multi-center, randomized phase III trial has found that a three-week hypofractionated radiotherapy (HypoRT) schedule with concurrent chemotherapy provides similar survival outcomes and reduced toxicity compared to the standard six-week conventional fractionated radiotherapy (ConvRT) schedule for patients with limited-stage small cell lung cancer (LS-SCLC).

838. Florida's plan to drop school vaccine rule won't start for 90 days, won't cover all diseases

  • 2 weeks ago schedule
  • medicalxpress.com language

Florida's plan to drop school vaccine mandates likely won't take effect for 90 days and would include only chickenpox and a few other illnesses unless lawmakers decide to extend it to other diseases, like polio and measles, the health department said Sunday.

839. Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

  • 2 weeks ago schedule
  • medicalxpress.com language

New research indicates that many patients who undergo surgery with the intent to cure early‐stage cancer continue or start opioid prescriptions in the year following surgery. The findings are published in Cancer.

840. Black youth, especially Black girls, use mental health services less than their white peers, study finds

  • 2 weeks ago schedule
  • medicalxpress.com language

Black adolescents with mental distress are less likely to use mental health services than their white peers, and Black girls are the least likely to access care, according to new research published in the Canadian Medical Association Journal.

841. Canada must protect youth from sports betting advertising, say specialists

  • 2 weeks ago schedule
  • medicalxpress.com language

Canada must enact strong, effective legislation to protect youth from gambling advertising. Minors are suffering harms from problem gambling despite age restrictions, argue authors in an editorial in CMAJ (Canadian Medical Association Journal).

842. What actually happens in your brain when you change your mind?

  • 2 weeks ago schedule
  • medicalxpress.com language

Imagine a game show where the host asks the contestant to randomly pick one option out of three: A, B or C.

843. Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

  • 2 weeks ago schedule
  • medicalxpress.com language

Patients diagnosed with recurrent or progressive extensive-stage small cell lung cancer (ES-SCLC) may benefit from treatment with ifinatamab deruxtecan (I-DXd), a B7-H3–directed antibody–drug conjugate, according to data presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC) in Barcelona, Spain.

844. First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer

  • 2 weeks ago schedule
  • medicalxpress.com language

A first-in-human Phase I study of SHR-4849 (IDE849), a Delta-like ligand 3 (DLL3)-directed antibody-drug conjugate (ADC), demonstrated manageable safety and early signs of anti-tumor activity in patients with relapsed small cell lung cancer (SCLC).

845. Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

  • 2 weeks ago schedule
  • medicalxpress.com language

Blood pressure matters at all ages. Children with higher blood pressure at age 7 may be at an increased risk of dying of cardiovascular disease by their mid-50s, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2025, held in Baltimore, September 4–7, 2025.

846. AI helps older adults report accurate blood pressure readings at home

  • 2 weeks ago schedule
  • medicalxpress.com language

Artificial intelligence (AI) voice agents helped older adults with high blood pressure to accurately report their blood pressure readings and improved blood pressure management, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2025 held in Baltimore, September 4–7, 2025.

847. What suicidal teens say matters most to them

  • 2 weeks ago schedule
  • medicalxpress.com language

Why would a suicidal teenager choose to live? It's not the kind of question most of us ever want to ask. Suicide is the third leading cause of death among 15–29-year-olds worldwide. Much of the research and media coverage still focuses on why teens might want to die. Far less often do we ask the opposite, equally urgent question: what makes life worth holding on to?

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.